Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
20.6M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
+808K
-
Total reported value, excl. options
-
$80.5M
-
Value change
-
+$5.41M
-
Number of buys
-
21
-
Number of sells
-
-14
-
Price
-
$6.69
Significant Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) as of Q3 2025
44 filings reported holding ACTU - ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share as of Q3 2025.
ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.000001 per share (ACTU) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 20.6M outstanding shares and own 58.33% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (10M shares), Voss Capital, LP (896K shares), VANGUARD GROUP INC (316K shares), BlackRock, Inc. (282K shares), GEODE CAPITAL MANAGEMENT, LLC (145K shares), NORTHERN TRUST CORP (85.5K shares), STATE STREET CORP (49.9K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (19.3K shares), Gleason Group, Inc. (19K shares), and SFMG, LLC (17K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.